CBMG
Cellular Biomedicine Group, Inc.
CBMG
CBMG
Delisted
CBMG was delisted on the 19th of February, 2021.
30 hedge funds and large institutions have $18.9M invested in Cellular Biomedicine Group, Inc. in 2016 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 16 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
30
Holders Change
-3
Holders Change %
-9.09%
% of All Funds
0.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
16
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Morgan Stanley
New York
| $2K | -$2.25K | -108 | -53% |
|
|
MFS
27
MSI Financial Services
Springfield,
Massachusetts
| $2K | – | – | – |
|
28
BNP Paribas Financial Markets
Paris,
France
| $1.49K | -$31.3K | -1,676 | -95% |
|
|
TRCT
29
Tower Research Capital (TRC)
New York
| $1K | -$3.37K | -101 | -77% |
|
30
Geode Capital Management
Boston,
Massachusetts
| $974 | +$10 | +523 | +1% |
|
31
AQR Capital Management
Greenwich,
Connecticut
| – | -$242K | -11,293 | Closed |
|
32
RhumbLine Advisers
Boston,
Massachusetts
| – | -$200K | -9,307 | Closed |
|
33
Bank of America
Charlotte,
North Carolina
| – | -$5K | -238 | Closed |
|